Literature DB >> 16094709

Identification of proteins of human colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry.

Ying-Tao Zhang1, Yi-Ping Geng, Le Zhou, Bao-Chang Lai, Lv-Sheng Si, Yi-Li Wang.   

Abstract

AIM: To conduct the proteomic analysis of human colorectal carcinoma cell line, SW480 by using two-dimensional electrophoresis (2-DE) and matrix-assisted laser desorption /ionization-time of flight mass spectrometry (MALDI-TOFMS).
METHODS: The total proteins of human colorectal carcinoma cell line, SW480 were separated with 2-DE by using immobilized pH gradient strips and visualized by staining with silver nitrate. The gel images were acquired by scanner and 2-DE analysis software, Image Master 2D Elite. Nineteen distinct protein spots were excised from gel randomly and digested in gel by TPCK-trypsin. Mass analysis of the tryptic digest peptides mixture was performed by using MALDI-TOF MS. Peptide mass fingerprints (PMFs) obtained by the MALDI-TOF analysis were used to search NCBI, SWISS-PROT and MSDB databases by using Mascot software.
RESULTS: PMF maps of all spots were obtained by MALDI-TOF MS and thirteen proteins were preliminarily identified.
CONCLUSION: The methods of analysis and identification of protein spots of tumor cells in 2-DE gel with silver staining by MALDI-TOF MS derived PMF have been established. Protein expression profile of SW480 has been obtained. It is demonstrated that a combination of proteomics and cell culture is a useful approach to comprehend the process of colon carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16094709      PMCID: PMC4615410          DOI: 10.3748/wjg.v11.i30.4679

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

1.  Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide.

Authors:  M S Jordan; A Boesteanu; A J Reed; A L Petrone; A E Holenbeck; M A Lerman; A Naji; A J Caton
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

Review 2.  The yin-yang of PR-domain family genes in tumorigenesis.

Authors:  G L Jiang; S Huang
Journal:  Histol Histopathol       Date:  2000-01       Impact factor: 2.303

3.  Improvement of in-gel digestion protocol for peptide mass fingerprinting by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  H Katayama; T Nagasu; Y Oda
Journal:  Rapid Commun Mass Spectrom       Date:  2001       Impact factor: 2.419

Review 4.  Analysis of HLA expression in human tumor tissues.

Authors:  Teresa Cabrera; Miguel Angel López-Nevot; Jose Juan Gaforio; Francisco Ruiz-Cabello; Federico Garrido
Journal:  Cancer Immunol Immunother       Date:  2002-12-10       Impact factor: 6.968

5.  Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters.

Authors:  François Bertucci; Sébastien Salas; Séverine Eysteries; Valéry Nasser; Pascal Finetti; Christophe Ginestier; Emmanuelle Charafe-Jauffret; Béatrice Loriod; Loïc Bachelart; Jérôme Montfort; Geneviève Victorero; Frédéric Viret; Vincent Ollendorff; Vincent Fert; Marc Giovaninni; Jean-Robert Delpero; Catherine Nguyen; Patrice Viens; Geneviève Monges; Daniel Birnbaum; Rémi Houlgatte
Journal:  Oncogene       Date:  2004-02-19       Impact factor: 9.867

6.  Evolution of enzymatic activity in the enolase superfamily: structural studies of the promiscuous o-succinylbenzoate synthase from Amycolatopsis.

Authors:  James B Thoden; Erika A Taylor Ringia; James B Garrett; John A Gerlt; Hazel M Holden; Ivan Rayment
Journal:  Biochemistry       Date:  2004-05-18       Impact factor: 3.162

7.  Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?

Authors:  Derek Atkins; Soldano Ferrone; Gerd E Schmahl; Stefan Störkel; Barbara Seliger
Journal:  J Urol       Date:  2004-02       Impact factor: 7.450

8.  Intermediate filaments in rat pancreatic acinar tumors, human ductal carcinomas, and other gastrointestinal malignancies.

Authors:  K H Herzig; M Altmannsberger; U R Fölsch
Journal:  Gastroenterology       Date:  1994-05       Impact factor: 22.682

9.  High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas.

Authors:  T Cabrera; A Collado; M A Fernandez; A Ferron; J Sancho; F Ruiz-Cabello; F Garrido
Journal:  Tissue Antigens       Date:  1998-08

10.  Major histocompatibility complex status in breast carcinogenesis and relationship to apoptosis.

Authors:  Maximino Redondo; Julian García; Eduardo Villar; Isabel Rodrigo; Emilio Perea-Milla; Alfonso Serrano; Miguel Morell
Journal:  Hum Pathol       Date:  2003-12       Impact factor: 3.466

View more
  4 in total

1.  In silico analysis and in vivo tests of the tuna dark muscle hydrolysate anti-oxidation effect.

Authors:  Jiaojiao Han; Shasha Tang; Yanyan Li; Wei Bao; Haitao Wan; Chenyang Lu; Jun Zhou; Ye Li; Lingzhi Cheong; Xiurong Su
Journal:  RSC Adv       Date:  2018-04-17       Impact factor: 4.036

Review 2.  Prediction of individual response to anticancer therapy: historical and future perspectives.

Authors:  Florian T Unger; Irene Witte; Kerstin A David
Journal:  Cell Mol Life Sci       Date:  2014-11-12       Impact factor: 9.261

3.  Autonomous inhibition of apoptosis correlates with responsiveness of colon carcinoma cell lines to ciglitazone.

Authors:  David M Baron; Ulrike Kaindl; Verena J Haudek-Prinz; Editha Bayer; Clemens Röhrl; Christopher Gerner; Brigitte Marian
Journal:  PLoS One       Date:  2014-12-11       Impact factor: 3.240

4.  Increased serum protein levels by Yuanshi Shengmai Chenggu Tablet in treatment of avascular osteonecrosis of the femoral head.

Authors:  Jianchun Zeng; Peng Deng; Jie Li; Wenjun Feng; Jinlun Chen; Yirong Zeng
Journal:  Mol Med Rep       Date:  2017-11-20       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.